Last year Abbott went ahead with a spin off into two major
business units, following that for Pfizer speculation started to surface that
it is also going for Split off in early Jan 2013, but yes the decision came in
July about splitting of the company. Now it’s turn for Novartis as the CEO
announced that he is certainly going to make some changes.....what we have to
see if Chiron will still exist in the port folio or they will merge it with
Pharma Biological and Vaccine innovation research....time will tell what will
be the next steps for Novartis
